Search

Dr Sherif Raouf

Clinical oncology 04661029

 

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Colon
  • Gynaecology
  • Lower GI
  • Lung
  • Upper GI

Offers

  • Video and telephone consultations
  • Home chemotherapy

Areas of interest

Chemotherapy; Radiotherapy (including RapidArc and SABR radiotherapy); Specialising in Pancreatic cancers; Oesophageal cancer; Neuroendocrine tumours; Rectal cancer; Colon cancer; Gastro-intestinal oncology; Gastro-intestinal disease; Ovarian cancer; Mouth cancer; Prostate cancer: Lung cancer; Gynaecological oncology; Head and Neck cancer, keloid radiotherapy

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

    Nuffield Health The Holly Hospital (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Nuffield Health The Holly Hospital (1-5)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.